June 22-23, 2022
In 2020, pharmaceutical companies turned to their PR professionals and agencies to get out messages about drug supply, patient support, public health reminders, vaccine updates and COVID protocols. However, now it is more important to focus on “the next normal” and understand how healthcare and pharmaceutical professionals can improve relationships with the public in this ‘post covid-19’ world.
SPEAKER HIGHLIGHTS
Christine Lindenboom
Senior Vice President, Investor Relations and Corporate Communications - ALNYLAM PHARMACEUTICALS
Eric Althoff
Principal and Owner - FINISH LINE COMMUNICATIONS STRATEGIES
Amy Atwood
Head of Communications, Vaccine Business Unit - TAKEDA PHARMACEUTICALS
Sarah Connors
Executive Director, Head of U.S. Communications - ONCOPEPTIDES
Shanelle Gabriel
Artist, Educator - LUPUS ADVOCATE
Madeline Gooding
Director, Corporate Communications - PACIRA PHARMACEUTICALS
Staci Gouveia
Director – Corporate Communications and Public Relations - AFAXYS
Heather Hunter
Vice President, Communications - VENATORX PHARMACEUTICALS
Laura J. Keller
Director, Head of CEO Communications - BIOGEN
Morris Kimble
Associate Director, Digital Marketing - ABBVIE
Matthew Libassi
Lead Media Relations Specialist - NORTHWELL HEALTH’S FEINSTEIN INSTITUTES
Christine Lindenboom
Senior Vice President, Investor Relations and Corporate Communications - ALNYLAM PHARMACEUTICALS
Heather Zoumas Lubeski
Vice President, Corporate Affairs - ENDO INTERNALTIONAL
Kristian Lysgaard
Director, Head of Global Communication, Center of Expertise - LEO PHARMA
Stephanie Marchesi
President, WE Global Health & North America Eastern Region - WE COMMUNICATIONS
Penny Mitchell
Senior Director, Marketing & Communications - LUPUS RESEARCH ALLIANCE
Diana Moore
Head of Global Corporate Communications - AMICUS THERAPEUTICS
Shweta Munjal
Vice President and Global Head, Corporate Communication - LUPIN PHARMACEUTICALS
Paul Murasko
Senior Director, Digital Customer Interaction - IPSEN PHARMACEUTICALS
Anna Padula
Director of Communications, US Specialty Pharmaceuticals - GLAXOSMITHKLINE
Laure Park
Senior Vice President, Investor Relations and Corporate Affairs - ENDO INTERNALTIONAL
Roslyn Patterson
Vice President, Marketing and Communications - IONIS PHARMACEUTICALS
Monica Perez
Director – Corporate Affairs - NOVEN PHARMACEUTICALS
Amanda Phraner
Senior Manager, Public Affairs and Social Media - HORIZON THERAPEUTICS
Michelle Rivas
Senior Manager, Product Communications - HORIZON THERAPEUTICS
Tierney Saccavino
Executive Vice President, Corporate Communications - ACORDA THERAPEUTICS
Helen Tarleton
Associate Director, Corporate Communications - UCB
TOP REASONS TO ATTEND
- Understanding where and how to shape your business strategies within your organization due to the increased importance of communication teams and roles
- Leveraging communication to connect with patients and making the public to be confident enough to openly communicate
- Focusing on an insight-driven and audience-centric approach to ensure stakeholders and professionals relay the message to the public in a meaningful way
- Discuss how to improve marketing and communications with HCPs by utilizing tools to determine data and KPIs
- Determine sustainable long-term and short-term goals and how you would want to grow your organization
WHO SHOULD ATTEND
Pharmaceutical, Biotechnology, and Medical Device Public Relations Practitioners whose responsibilities include:
Communications:
- Corporate/Brand/Internal/
External/Integrated/ Multichannel/Crisis - Public Relations/Media Relations
- Marketing
- Public Affairs/Government Affairs
- Public Policy
- Community Relations/Advocacy Relations
- Social Media
- Brand Managers
- Product Managers
- Communications Agencies
- Publications
- Data Analytic Firms
PARTNERS
Media Partners
Interested in Sponsoring? Contact Jayson Mercado at jayson@momentumevents.com